Medicare Changes For Medtech In 2020: What’s Ahead
The US Centers for Medicare and Medicaid Services (CMS) has finalized many new coverage policy decisions and coverage rules taking effect in 2020. Medtech Insight provides a review of what industry can expect this year from the Medicare agency.
You may also be interested in...
The US Medicare agency is allowing more device procedures to be conducted at outpatient hospitals and ambulatory surgical centers (ASC), while approving several new devices for passthrough payments for three years under its Outpatient Prospective Payment System and ASC payment system final rule for 2020, released on 1 November.
Suppliers of infusion pumps and related supplies for homebound patients are entitled to payment for each visit, including coverage of professional nursing services, training and education, and monitoring of patients, says a US Medicare agency 2020 final rule on home-health benefits released on 1 November.
There is sufficient evidence to expand coverage of next-generation sequencing (NGS) as a diagnostic test for ovarian, breast or other advanced cancers if certain criteria are met, the Centers for Medicare and Medicaid Services wrote in a 30 October proposed decision memo.